Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Medirom Healthcare Technologies Inc

Consumer Cyclical US MRM

1.0401USD
-0.0599(5.45%)

Last update at 2026-06-23T17:22:00Z

Day Range

1.041.13
LowHigh

52 Week Range

3.507.40
LowHigh

Fundamentals

  • Previous Close 1.10
  • Market Cap26.46M
  • Volume13708
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA134.90M
  • Revenue TTM7049.80M
  • Revenue Per Share TTM1445.40
  • Gross Profit TTM 1415.41M
  • Diluted EPS TTM-0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -414.48100M -414.48100M -1062.78000M 32.74M 91.92M
Minority interest - - - - -
Net income -990.73100M -990.73100M -1079.65100M 17.34M 66.31M
Selling general administrative 1805.49M 1822.79M 678.55M 871.86M 842.82M
Selling and marketing expenses - - 56.08M - -
Gross profit 1415.41M 1415.41M 317.68M 950.76M 956.87M
Reconciled depreciation 184.06M 126.24M 33.09M 46.17M 44.27M
Ebit -379.53000M -379.53000M -578.01900M 84.39M 114.96M
Ebitda -228.07100M -228.07100M -931.54400M 130.56M 159.23M
Depreciation and amortization 151.46M 151.46M -353.52500M 46.17M 44.27M
Non operating income net other - - - - -
Operating income -379.53000M -379.53000M -578.01900M 84.39M 73.27M
Other operating expenses 5789.35M 5789.35M 1994.13M 3829.37M 3319.09M
Interest expense 11.95M 11.95M 12.79M 13.59M 15.48M
Tax provision 30.81M 576.25M 16.87M 15.96M 25.25M
Interest income 6.07M 0.84M 0.67M 1.34M 0.79M
Net interest income -3.72800M -11.11100M -12.12500M -12.25500M -14.70000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 576.25M 576.25M 16.87M 15.96M 25.25M
Total revenue 5409.82M 5409.82M 1416.11M 3908.26M 3433.14M
Total operating expenses 1794.94M 1794.94M 895.70M 871.86M 842.82M
Cost of revenue 3994.41M 3994.41M 1098.43M 2957.51M 2476.27M
Total other income expense net -34.95100M -34.95100M -484.76100M -51.64800M -7.42500M
Discontinued operations - - - - -
Net income from continuing ops 148.97M -990.73100M -1079.65100M 17.34M 66.31M
Net income applicable to common shares - -990.73100M -539.17000M 17.34M 66.31M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 5753.06M 5753.06M 3041.59M 4757.47M 4521.98M
Intangible assets 391.04M 391.04M 47.18M 77.64M 76.28M
Earning assets - - - - -
Other current assets 111.17M 111.17M -19.11100M 47.48M 40.04M
Total liab 5961.40M 5961.40M 2661.73M 4157.41M 4639.53M
Total stockholder equity -208.34300M -208.34300M 379.87M 600.06M -117.55500M
Deferred long term liab - - - 57.51M -
Other current liab 1943.92M 1943.92M 795.60M 581.38M 505.25M
Common stock 1223.23M 1223.23M 1179.41M 595.10M 245.10M
Capital stock 1223.23M 1223.23M 1179.41M 595.10M 245.10M
Retained earnings -2694.03300M -2694.03300M -2095.53900M -705.30900M -722.64400M
Other liab - 889.61M 908.35M 607.39M 621.80M
Good will 600.33M 600.33M 65.79M 78.28M 63.95M
Other assets - 1077.28M 0.00300M 1209.85M 1122.70M
Cash 370.62M 370.62M 244.57M 513.62M 211.69M
Cash and equivalents - - - - -
Total current liabilities 3196.47M 3196.47M 1493.90M 2262.69M 2350.81M
Current deferred revenue 104.18M 104.18M 442.39M 483.12M 522.30M
Net debt 2422.18M 2422.18M 644.87M 1849.30M 2637.18M
Short term debt 917.47M 917.47M 221.06M 1075.59M 1181.94M
Short long term debt 99.17M 162.25M 221.06M 371.57M 413.74M
Short long term debt total 2792.80M 2792.80M 889.44M 2362.92M 2848.86M
Other stockholder equity 1262.46M 1262.46M 1295.99M 710.27M 360.27M
Property plant equipment - 2249.09M 1814.76M 1998.92M 2273.02M
Total current assets 1382.30M 1382.30M 1922.24M 1378.73M 934.04M
Long term investments 53.02M 53.02M 2.39M 14.04M 51.98M
Net tangible assets - -1199.71000M 242.92M 444.14M -257.79100M
Short term investments 26.53M 26.53M 32.52M 38.52M 33.02M
Net receivables 855.29M 855.29M 1688.83M 773.59M 642.88M
Long term debt 1149.77M 746.59M 668.38M 150.53M 342.77M
Inventory 18.70M 18.70M 7.96M 5.51M 6.40M
Accounts payable 230.90M 230.90M 34.85M 122.59M 141.32M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - -125.81800M -74.11000M -0.27800M
Additional paid in capital - - - - -
Common stock total equity - - 1179.41M 595.10M 245.10M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 107.22M 107.22M 165.30M 987.34M 894.34M
Deferred long term asset charges - - - - -
Non current assets total 4370.76M 4370.76M 1119.35M 3378.74M 3587.94M
Capital lease obligations 1982.40M 1883.96M 1651.21M 1840.82M 2092.35M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 580.44M -72.92200M 36.30M -45.44400M -79.38800M
Change to liabilities - -104.35600M -216.16900M -18.72900M 88.51M
Total cashflows from investing activities - -83.93600M -139.59900M -37.93100M -79.38800M
Net borrowings - -253.97200M -253.97200M -241.91100M -74.47500M
Total cash from financing activities -427.94900M -427.94900M 1432.13M 331.99M -74.47500M
Change to operating activities - 147.97M 80.42M -32.53000M -157.48100M
Net income -990.73100M -990.73100M -539.17000M 17.34M 66.31M
Change in cash -1069.11600M -1069.11600M 926.11M 301.93M -11.99100M
Begin period cash flow 1439.73M 1439.73M 513.62M 211.69M 223.68M
End period cash flow 370.62M 370.62M 1439.73M 513.62M 211.69M
Total cash from operating activities -557.23100M -557.23100M -366.42000M 7.87M 141.87M
Issuance of capital stock 0.00000M 0.00000M 1168.63M 700.00M 0.00000M
Depreciation 126.24M 126.24M 62.29M 46.17M 44.27M
Other cashflows from investing activities - 48.07M 23.30M 24.74M 33.90M
Dividends paid - - - - -
Change to inventory -2.44100M -2.44100M -2.44500M 0.89M 6.92M
Change to account receivables -37.02400M -37.02400M 189.14M -66.87700M 30.17M
Sale purchase of stock - - - - -
Other cashflows from financing activities -176.86500M -176.86500M 649.94M -126.09500M 270.00M
Change to netincome - 306.01M 34.15M 57.41M 58.66M
Capital expenditures 113.78M 113.78M 104.12M 19.47M 50.12M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.25M 1.25M 76.31M -113.04400M -27.36800M
Stock based compensation 196.85M 196.85M 139.51M 59.05M 0.15M
Other non cash items -442.32800M -442.32800M 1.90M -7.38200M 40.05M
Free cash flow -671.00900M -671.00900M -470.54500M -11.60400M 91.76M

Peer Comparison

Sector: Consumer Cyclical Industry: Personal Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MRM
Medirom Healthcare Technologies Inc		 -0.0599 5.45% 1.04 - - 0.0042 18.23 0.0071 0.25
ROL
Rollins Inc		 0.23 0.52% 44.64 51.78 39.22 6.88 18.58 7.13 31.73
SCI
Service Corporation International		 0.45 0.62% 73.61 21.36 18.55 2.46 6.15 3.54 12.26
HRB
H&R Block Inc		 1.60 4.70% 35.64 13.51 11.21 1.96 26.62 2.38 8.97
BFAM
Bright Horizons Family Solutions Inc		 1.11 1.73% 65.13 25.30 15.02 1.64 3.49 2.14 15.38

Reports Covered

Stock Research & News

View All

Profile

MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, an on-demand health monitoring smartphone application and MOTHER Bracelet for fitness applications; and preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Medirom Healthcare Technologies Inc

Tradepia Odaiba, Tokyo, Japan, 135-0091

Key Executives

Name Title Year Born
Mr. Kouji Eguchi CEO & Representative Director 1974
Mr. Fumitoshi Fujiwara CFO & Director 1966
Mr. Akira Aoki Exec. Officer & Chief Medical Officer NA
Mr. Akira Aoki Executive Officer & Chief Medical Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions